Getting in the holiday spirit: Fundraising to end T1D
Christmas light displays and cookies for a cure: Here's how some Breakthrough T1D community members are raising funds this holiday season.
Breakthrough T1D Ride 2025 Wrapped
You rode. We cheered you on. Together, we fueled type 1 diabetes breakthroughs! Read our wrap-up of the Breakthrough T1D Ride 2025 season.
Q&A with San Diego Padres Pitcher Mason Miller
Breakthrough T1D sat down with Mason Miller to learn more about his journey with type 1 diabetes and the impact it has on him as an athlete.
My Cause, My Cleats: Lacing up to drive meaningful change
Breakthrough T1D is honored to have the support of nine NFL players, coaches, and staff for the 2025 My Cause, My Cleats initiative.
Support and resources for your CGM
Support and resources for issues with continuous glucose monitors (CGMs), including inaccurate readings and faulty sensors.
Smart devices, angry skin: The underside of diabetes tech
Skin reactions from adhesives on insulin pumps and CGMs are common. Learn why they occur and how to reduce irritation.
See Medical Affairs. See T1D.
Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.
A week-long, intercontinental marathon journey for type 1 diabetes
Forrest Johnson embarked on a globe-spanning, 184-mile sprint with The Great World Race to fundraise for type 1 diabetes research.
See our advocates. See T1D.
Through grassroots support, Breakthrough T1D advocates help advance treatments, influence policy, and improve global access to care.
Cardiovascular disease and T1D: Advancing breakthroughs in Europe and beyond
What’s happening? Today, Breakthrough T1D co-hosted an event with leading international diabetes organizations to discuss cardiovascular disease (CVD) and type 1 diabetes (T1D)—where we are, challenges that remain, and how we can work together in Europe and beyond to address this need for the T1D community. The focus of the event: Doing more for CVD […]
